Schmidt, A F, Swerdlow, D I, Holmes, M V, Patel, R S, Fairhurst-Hunter, Z, Lyall, D M, Hartwig, F P, Horta, B L, Hyppönen, E, Power, C, Moldovan, M, van Iperen, E, Hovingh, G K, Demuth, I, Norman, K, Steinhagen-Thiessen, E, Demuth, J, Bertram, L, Liu, T, Coassin, S, Willeit, J, Kiechl, S, Willeit, K, Mason, D, Wright, J, Morris, R, Wanamethee, G, Whincup, P, Ben-Shlomo, Y, McLachlan, S, Price, J F, Kivimaki, M, Welch, C, Sanchez-Galvez, A, Marques-Vidal, P, Nicolaides, A, Panayiotou, A G, Onland-Moret, N C, van der Schouw, Y T, Matullo, G, Fiorito, G, Guarrera, S, Sacerdote, C, Wareham, N J, Langenberg, C, Scott, R, Grarup, N, Pedersen, O, Hansen, T, Linneberg, A & LifeLines Cohort study group 2017, ' PCSK9 genetic variants and risk of type 2 diabetes : a mendelian randomisation study ', The Lancet Diabetes & Endocrinology, vol. 5, no. 2, pp. 97–105 . https://doi.org/10.1016/S2213-8587(16)30396-5 Lancet Diabetes & Endocrinology, 5(2), 97-105. ELSEVIER SCIENCE INC